Xencor Inc financial data

Symbol
XNCR on Nasdaq
Industry
Pharmaceutical Preparations
Location
465 N. Halstead St., Suite 200, Pasadena, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 688 % -36.9%
Debt-to-equity 42.1 % +160%
Return On Equity -30.9 % -79.2%
Return On Assets -21.7 % -46.4%
Operating Margin -254 % -150%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70M shares +15%
Common Stock, Shares, Outstanding 70M shares +15.3%
Entity Public Float 1.5B USD -7.52%
Common Stock, Value, Issued 701K USD +15.5%
Weighted Average Number of Shares Outstanding, Basic 64M shares +5.61%
Weighted Average Number of Shares Outstanding, Diluted 64M shares +5.61%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 85.2M USD -41.4%
Research and Development Expense 240M USD -0.96%
General and Administrative Expense 61.6M USD +21.1%
Operating Income (Loss) -216M USD -46.4%
Nonoperating Income (Expense) 20.3M USD -27.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -46.3M USD -90.8%
Income Tax Expense (Benefit) 5.93M USD
Net Income (Loss) Attributable to Parent -198M USD -66.6%
Earnings Per Share, Basic -3.18 USD/shares -59%
Earnings Per Share, Diluted -3.18 USD/shares -59.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29M USD -44.9%
Accounts Receivable, after Allowance for Credit Loss, Current 10.2M USD -81.4%
Assets, Current 573M USD +0.38%
Property, Plant and Equipment, Net 62.4M USD -8.28%
Operating Lease, Right-of-Use Asset 38.8M USD +11.6%
Intangible Assets, Net (Excluding Goodwill) 17.9M USD -4.4%
Other Assets, Noncurrent 498K USD -24.5%
Assets 984M USD +26.4%
Accounts Payable, Current 18.8M USD +25.4%
Accrued Liabilities, Current 25.4M USD +3.82%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 92M USD +73.4%
Operating Lease, Liability, Noncurrent 66.5M USD +17.9%
Liabilities 263M USD +140%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.8M USD
Retained Earnings (Accumulated Deficit) -644M USD -44.5%
Stockholders' Equity Attributable to Parent 724M USD +8.2%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 721M USD +7.76%
Liabilities and Equity 984M USD +26.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -55.3M USD -80.5%
Net Cash Provided by (Used in) Financing Activities 186K USD -79.8%
Net Cash Provided by (Used in) Investing Activities 32.3M USD -32.9%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 70M shares +15.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.8M USD -223%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 29.4M USD -44.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 11K USD +57.1%
Deferred Tax Assets, Valuation Allowance 158M USD +37.5%
Deferred Tax Assets, Gross 180M USD +34.4%
Operating Lease, Liability 68.7M USD +13%
Payments to Acquire Property, Plant, and Equipment 132K USD -98.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -196M USD -78.2%
Lessee, Operating Lease, Liability, to be Paid 103M USD -6.22%
Property, Plant and Equipment, Gross 102M USD +17%
Operating Lease, Liability, Current 2.18M USD -50.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.24M USD +15.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 8.02M USD +20%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure -22.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 32.3M USD -26.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.56M USD +3.49%
Deferred Tax Assets, Operating Loss Carryforwards 22.5M USD -31.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.08M USD -5.06%
Operating Lease, Payments 3.67M USD +13.8%
Additional Paid in Capital 1.36B USD +22.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.04M USD +35.2%
Deferred Tax Assets, Net of Valuation Allowance 21.8M USD +15.4%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%